In view of a clinical suspicion of CS, she underwent estimation of serum cortisol (at 8 am) along with plasma adrenocorticotropic hormone (ACTH). The levels of these were found to be > 75 mcg/dL (reference value 4.3–22.4 mcg/dL) and 363 pg/mL (reference value 10–60 pg/mL) respectively. This led to a diagnosis of ACTH-dependent Cushing syndrome. MRI cranium showed no evidence of pituitary or hypothalamic lesions. A contrast-enhanced computed tomography of the thorax and abdomen was performed for further evaluation of the etiology of endogenous Cushing syndrome. This showed evidence of a tumor in the tail of the pancreas, para-aortic and coeliac lymphadenopathy, evidence of metastasis to the liver, and bilateral adrenal hyperplasia (Fig.
2). Subsequently, the patient underwent distal pancreatectomy, bilateral adrenalectomy with nodal sampling, and liver nodule excision biopsy. Histopathological examination of the excised pancreatic specimen showed monomorphic tumor cells arranged in nests and sheets which showed moderate cytoplasm, fine stippled chromatin, and moderate degree of nuclear atypia. These cells were diffusely positive for immunohistochemistry with synaptophysin and chromogranin. The Ki-67 index was 40%. Hence, the final histopathology was suggestive of a well-differentiated pancreatic neuroendocrine tumor (World Health Organization Grade 3) with metastasis to celiac lymph node and liver nodule (Fig.
3). To summarize, she had a pancreatic neuroendocrine tumor producing ACTH, leading to endogenous CS. Post-operatively, she requires amlodipine (being tapered) and hydrocortisone. Stress dose of hydrocortisone was initiated. After multidisciplinary tumor board discussion, oral capecitabine and temozolamide chemotherapy were initiated.